Delivery Order SPE2DB22D3301-SPE2DB25FX7WE
Award Date
1/2/25
Potential Completion Date
1/3/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,668.90 firm fixed-price delivery order is for VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,304.73 firm-fixed-price delivery order is for the supply of Visipaque 320 mg/ml bottles (100 ml) and has an ultimate completion date of October 23, 2024.
Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $2,618.94 firm fixed-price contract is for the supply of VISIPAQUE 320 MG/ML infusion bottles. The contract has an ultimate completion date of December 4, 2024 and is not designated as a set-aside.
AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,966.52 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of October 28, 2022.
AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,118.34 firm fixed-price delivery order is for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a contrast agent used in medical imaging procedures. The contract has an ultimate completion date of August 2, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA...
This is a $1,687.64 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of VISIPAQUE 320 MG/ML infusion bottles, with a completion date of July 23, 2024. The contract was awarded on July 22, 2024, and is a firm fixed-price agreement. The award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,169.19 firm fixed-price delivery order is for the pharmaceutical product VISIPAQUE 320 MG/ML INFUS BTL 150ML, with a completion date of September 11, 2024. The contract is not designated with a set-aside requirement, indicating open competition.
Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,265.73, is for the delivery of VISIPAQUE 320 MG/ML INFUS BTL 150ML, a pharmaceutical product. The award is a Delivery Order under an existing Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,795.85, is a Firm Fixed Price Delivery Order for the supply of VISIPAQUE 320 MG/ML BOTTLE 100ML, a medical product used in healthcare settings. The award has an ultimate completion date of October 18, 2024. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,715.10 firm fixed-price delivery order is for the supply of VISIPAQUE 270 MG/ML BOTTLE 100ML, a pharmaceutical product, to support military healthcare programs.
The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...